Geoffrey Michael Glass, Director at AVADEL PHARMACEUTICALS PLC (AVDL), bought 4,800 shares at $6.78 ($33K) on 2020-08-28, disclosed to the SEC on 2020-09-01.
Open-market purchase of $33k AVDL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| AVDL | BUY | 2022-06-03 | $96K | — | Filing → |
| AVDL | BUY | 2022-06-02 | $96K | — | Filing → |
| AVDL | BUY | 2020-08-14 | $100K | — | Filing → |